| Financial Year |
March 31 2023 |
| Monetary Funds |
88,142,847.99 |
| Held-for-trading Financial Assets |
9,818,618.36 |
| Notes Receivable |
114,470,725.00 |
| Accounts Receivable |
1,398,805,545.08 |
| Advances to Suppliers |
326,827,497.09 |
| Other Receivables |
234,254,176.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
45,404,207.55 |
| Dividend Receivable |
-- |
| Inventories |
318,539,000.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
48,742,435.68 |
| Total Current Assets |
2,617,553,793.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,400,855,757.56 |
| Investment Properties |
-- |
| Fixed Assetes |
17,152,745.52 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,722,751,021.84 |
| R&D expenses |
-- |
| Goodwill |
2,976,718,735.51 |
| Long-Term Deferred and Prepaid Expenses |
3,960,853.92 |
| Deferred Income Tax Assets |
295,877,845.92 |
| Other Non-Current Assets |
1,171,245,406.20 |
| Sub-Total of Non-Current Assets |
7,679,729,319.75 |
| Total Assets |
10,297,283,112.76 |
| Short-Term Loans |
719,095,986.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
655,685,740.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,611,819.75 |
| Taxes Payable |
97,413,782.72 |
| Interest Payable |
3,478,509.73 |
| Dividend Payable |
11,549,956.81 |
| Other payables |
410,066,093.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,129,553.34 |
| Other Current Liabilities |
235,046,002.33 |
| Sub-Total of Current Liabilities |
2,641,369,721.65 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,398,204.99 |
| Other Non-Current Liabilities |
110,000,000.00 |
| Sub-Total of Non-Current Liabilities |
113,825,397.27 |
| Total Liabilities |
2,755,195,118.92 |
| Paid-In Capital(Or Share Stock) |
2,655,785,257.00 |
| Capital Surplus |
4,796,669,374.93 |
| Surplus Reserve |
173,411,853.60 |
| LESS:Treasury Stock |
162,667,889.00 |
| Undistributed Profits |
111,691,963.07 |
| Minority Stockholder's Interest |
676,376.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,541,411,617.03 |
| Owner's Equity（Stockholder's Equity） |
7,542,087,993.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,297,283,112.76 |
